LAVA Therapeutics N.V. (LVTX) Tops Q1 EPS by 19c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q1 EPS of ($0.13), $0.19 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• Intel (INTC) PT Lowered to $92 at Mizuho
• Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance
• Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance